GLOFITAMAB

GLOFITAMAB (15227K)

Glofitamab 10 mg/10 mL injection, 10 mL vial
15227K
Body System:
Manner of administration:Injection
Private
Chemotherapy Items for Private Hospital use
Authority Required

Restriction

Indication: Relapsed or refractory diffuse large B-cell lymphoma (DLBCL)
Treatment phase: Continuing treatment (Cycles 2-12)

Restriction

Indication: Relapsed or refractory diffuse large B-cell lymphoma (DLBCL)
Treatment phase: Transitioning from non-PBS to PBS-subsidised treatment - Grandfather arrangements
Quantities & Cost
Max amount # of repeats DPMA Max safety net General Patient Charge
Max amount: 30000 mcg # of repeats: 10 DPMA: $16,156.39 Max safety net: $25.00 General Patient Charge: $25.00
Available brands
Columvi
(Glofitamab 10 mg/10 mL injection, 10 mL vial)